Sentences with phrase «translational immunology»

Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

He has been a part of the Pillai group since 2011 and is keen on applying his knowledge and skills to problems in human translational immunology.

Special emphasis is given to research in the areas of integrative neuro - sciences, medical imaging, translational immunology and cancer research, microbiology and infection research, biochemistry and pharmaceutical research, plant molecular biology, geo - and environmental research, astro - and elementary particle physics, quantum physics and nanotechnology, archeology and prehistory, historical science, religion and cultures, language and cognition, media and educational research.

«If we delay the start of the rejection response, it should be milder and more easily controlled and lead to less late rejection,» said Pober, who is a co-author of the study and also director of Yale's Human and Translational Immunology program.

A sampling of presentations will highlight opportunities in reverse translational immunology research.

She is also the Director of the UNC Center for Translational Immunology and the co-Director of the Institute of Inflammatory Diseases.

A feasibility study: association between gut microbiota enterotype and antibody response to seasonal trivalent influenza vaccine in adults — Nick Shortt — Clinical and Translational Immunology

Together with the Director of the Institute of Translational Immunology, Professor Detlef Schuppan, Schattenberg is leading the LIFT - off (Lifestyle Intervention to prevent and improve hepatic fibrosis in non-alcoholic fatty liver disease) research initiative.

«It's difficult to assess something that doesn't provide the key methodology,» says Megan Sykes, director of the Columbia Center for Translational Immunology at Columbia University in New York.

The team of scientists was led by Science Foundation Ireland Stokes Professor of Translational Immunology, Padraic Fallon, of the School of Medicine in the Trinity Biomedical Sciences Institute.

Importantly, these cells are readily detectable in patients» bloodstream, allowing for any clinical tests to be minimally invasive and pain - free for patients,» said Professor Salvatore Albani, Director, SingHealth Translational Immunology and Inflammation Centre (STIIC), Professor, Duke - NUS Medical School and Senior Clinician Scientist, KK Women's and Children's Hospital (KKH), who is the principal investigator of the study.

A 2013 Clinical and Translational Immunology study found that when a baby is ill, the numbers of leukocytes in its mother's breast milk spike.)

Not exact matches

publishes basic, translational and clinical research specifically about immunology across all organisms and model systems, including humans.

AAAS — publisher of the journals Science, Science Translational Medicine, Science Signaling, Science Advances, Science Robotics, and Science Immunology — anticipates up to 10,000 attendees at its first Annual Meeting to be held in Austin.

AAAS, an international nonprofit scientific association established in 1849, publishes: Science, Science Advances, Science Immunology, Science Robotics, Science Signaling and Science Translational Medicine.

Individual subscriptions are also available to Science Translational Medicine, Science Signaling, Science Immunology or Science Robotics.

To encourage your library to get an institutional subscription to Science, Science Signaling, Science Translational Medicine, Science Immunology or Science Robotics please use our recommendation form.

Science publishes five other journals: Science Signaling, Science Translational Medicine, Science Immunology, Science Robotics, and our open access, interdisciplinary journal, Science Advances.

Access Policies for Science, Science Signaling, Science Translational Medicine, Science Immunology, and Science Robotics

Focusing on basic research for the functional regulation of innate and adaptive immunity and on translational research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology immunology community.

AAAS permits the use of content published in its journals Science, Science Immunology, Science Robotics, Science Signaling, and Science Translational Medicine, but only provided the following criteria are met:

AAAS publishes five other journals: Science, Science Signaling, Science Translational Medicine, Science Immunology, and our open access, interdisciplinary journal Science Advances.

In addition to the flagship journal Science, the Science family of journals includes Science Translational Medicine, Science Signaling, the open - access journal Science Advances, and — the newly introduced — Science Robotics and Science Immunology.

Dr. Bot is the editor - in - chief of International Reviews of Immunology and the section editor for immunology and immunotherapy for the Journal of TranslationalImmunology and the section editor for immunology and immunotherapy for the Journal of Translationalimmunology and immunotherapy for the Journal of Translational Medicine.

Watkins and Dennis Burton, Ph.D., chairman and professor of the Department of Immunology & Microbiology at the Scripps Research Institute, led the collaborative international study, «Neutralizing Human Monoclonal Antibodies Prevents Zika Virus Infection in Macaques,» published recently in Science Translational Medicine.

Please use this form to recommend that your library subscribes to or trials any of our journals, including Science (Online and Classic), Science Signaling, Science Translational Medicine, Science Immunology, and Science Robotics.

Vanderbilt Center for Immunobiology & Vanderbilt Center for Translational and Clinical Immunology

«The problem arises from autoimmunity, a condition that people with type 1 diabetes already have,» says Myra A. Lipes, M.D, investigator in the Section on Immunology at Joslin and principal investigator of a study published in the June 13 edition of the journal Science Translational Medicine.

At the dinner, Parker also received the organization's highest honor for lay individuals, the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strong ties.

The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.

While translational research has traditionally moved basic immunology knowledge forward into clinical application, varying clinical presentations of human immune - related disease processes, as well as variability in therapeutic outcomes, have provided opportunities for discovery of novel mechanistic hypotheses directly from patients.

The second laboratory continues to focus attention on transplantation immunobiology in mouse models and translational studies of human immunology in transplant recipients.

Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.

In addition, our basic science and translational research efforts — particularly in the areas of the gut microbiome, immunology, and microbiology — are contributing to the scientific advancement in the development, prevention, and treatment of IBD, and to the promise of more effective treatment strategies for future patients.

Michel Detheux, iTeos» Chief Executive Officer added, «The progress of our adenosine A2A antagonist program demonstrates how we can rapidly apply our expertise in medicinal chemistry, tumor immunology and translational medicine to advance candidates toward clinical development.»

Gosselies, Belgium — February 10, 2017 — iTeos Therapeutics SA, a Belgian privately - held biotechnology company applying its expertise in translational tumor immunology to the development of novel cancer immunotherapies, today announced that Michel Detheux, iTeos» Chief Executive Officer, will present at the 2017 BIO CEO & Investor Conference on Tuesday, February 14 2017 at 10:45 a.m. ET in Park North at The Waldorf Astoria in New York, NY.

Across 20 years, I have published more than 150 clinical and translational publications with a focus on the cell biology of melanoma and immunology and patented eight novel therapies.

iTeos» competitive edge is in the combination of expertise in drug discovery and translational tumor immunology.

The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society and publisher of the journal Science (www.sciencemag.org) as well as Science Translational Medicine, Science Signaling, a digital, open - access journal, Science Advances, Science Immunology, and Science Robotics.

The scientific focus of our group is at the crossroads of Immunology, Inflammation, Vascular Medicine and Metabolism; we try to merge Basic Science and Translational Medicine by engaging preclinical translational aTranslational Medicine by engaging preclinical translational atranslational animal models.

Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers

Fascinated by human immunology and translational research, I undertook my PhD in tumor immunology at the University of Tuebingen (Germany).

Promoting and disseminating research and good practice in immunology, translational medicine and vaccination

Warner Greene's primary affiliation is with the Gladstone Institute of Virology and Immunology, where he is director and the Nick and Sue Hellman Distinguished Professor of Translational Medicine and where his laboratory is located and his research is conducted.

In 2006, I crossed the English Channel to go learn more about human immunology and translational research in Southampton (Pr.

Michael A. Davies, M.D., Ph.D., Associate Professor and Deputy Chairman, Department of Melanoma Medical Oncology and Associate Professor, Department of Systems Biology, Department of Translational Molecular Pathology University of Texas MD Anderson Cancer Center «Integrated interrogation of oncogenic signaling pathways, immunology, and heterogeneity in cancer»

«Our strategy will be to exploit the innate immune system to help flush the virus out of hiding and ultimately to eliminate its ability to bounce back when drug treatment ends,» said Greene, a professor of medicine, microbiology and immunology at UCSF, and the Nick and Sue Hellmann Distinguished Professor of Translational Medicine at Gladstone.

Elizabeth Winzeler, PhD Professor of Pediatrics, Division of Pharmacology and Drug Discovery University of California, San Diego, School of Medicine Director of Translational Research, UC Health Sciences Center for Immunology, Infection and Inflammation Talk title: Using chemical genomics to find new targets for malaria elimination

Vice President, Scientific Operations Herbert Kean, M.D., Family Endowed Chair Professor Director, HIV - 1 Immunopathogenesis Laboratory Professor, Translational Tumor Immunology Program Professor, Vaccine & Immunotherapy Center Associate Director for Shared Facilities, Wistar Cancer Center

In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., program leader of Wistar's Translational Tumor Immunology program, and his research team identified a marker for myeloid - derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.